Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Screening Considerations: Balancing the Benefits and Risks

TARDIS: The Improved Method of Detecting Breast Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Hypoxia Markers and Their Importance

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cutaneous Manifestations of Internal Malignancy

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Pediatric Cancer

Cancer Symptoms

The Biochemistry of Breast Cancer Screening

See more featured articles »

Insights into Oncofertility

Secondary Brain Cancer

Why are Cancer Cell Lines Useful?

Cancer Pain

Cancer Classification

Using Biomarkers to Detect Cancer

Living with Cancer Pain

The Cancer Cell Surface Proteome as a Therapeutic Target

Investigating the Molecular Mechanisms of Cancer

What is Merkel Cell Carcinoma?

What is Cancer?

Cancer Epidemiology

Exploiting Enzymes in Cancer Diagnosis and Therapy

Assay for Monitoring and Treating Malignant Brain Tumors

What Role do Biobanks Play in Cancer Research?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

The Effects of Cancer on Family Life

Targeted Cancer Therapies

Transforming Cancer Care through Genomic Testing

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

What is Immunochemotherapy?

Cancer Diagnosis

Insight into Cancer Vaccines

What is Tumorigenesis?

Cancer Glossary

Acidosis and Tumor Progression

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Pain Management

What is the Tumor Microenvironment?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Research

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Prognosis

Overview of Cell Viability and Cytotoxicity

Caring for a Loved One with Cancer

What is Cancer of Unknown Primary?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Pathophysiology

Microfluidic cancer treatment screen combined with flow cytometry

Is Cancer a Metabolic Disorder?

Myc Mutations and Cancer

British Pioneers in Cancer Biology

Cancer History

Secondary Lung Cancer

What Causes Cancer?

Hot vs Cold: the differences between tumor types

Cancer Prevention: Lowering your Risk

Cancer Management

CDK9 and Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Latest Cancer News and Research

Younger mismatched donors offer new hope for blood cancer patients

Blood cancer patients who cannot find a closely matched stem cell donor may have more transplant options than previously thought.

21 Aug 2026

KAIST research opens new path toward releasing 'molecular lock' and reversing cell's fate

Once a cell has locked into an abnormal state — the way cancer cells do — can it ever be restored back to normal? A KAIST research team has identified the 'molecular lock' that keeps cells trapped in an altered state, opening a new path toward releasing that lock and reversing a cell's fate.

21 Aug 2026

Multifunctional nanoplatform addresses three key barriers to effective TNBC immunotherapy

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15-20% of all cases.

21 Aug 2026

Bonsai software visualizes complex biological data as branching trees

Modern biology research can now generate valuable data on an unprecedented scale. But there is one major obstacle: making sense of these complex high-dimensional datasets.

21 Aug 2026

Antibodies for visualizing cell identity and tumor architecture

Whether you are characterizing cell state transitions, assessing organelle integrity, or building a multiplex immunofluorescence (IF) assay, you need reliable structural markers for your imaging.

From Antibodies Incorporated 21 Aug 2026

Scientists identify molecule driving one of the deadliest forms of breast cancer

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

21 Aug 2026

Younger lung cancer patients show more targetable gene alterations

Younger adults with non-small cell lung cancer are significantly more likely than older patients to have genetic alterations that can be matched with targeted therapies, according to a large international study led in part by researchers at Sylvester Comprehensive Cancer Center part of the University of Miami Miller School of Medicine.

21 Aug 2026

Cryo-EM provides real-time glimpse of cellular machinery reading DNA inside living organisms

All living things have a fleet of tiny copy machines that turn instructions from DNA into RNA, the molecules responsible for helping build proteins that keep organisms alive.

20 Aug 2026

Scientists uncover safer way to tame cancer cell senescence

Stopping tumor growth is only half the battle. Rather than kill tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells will continue to release signals that reshape the tumor environment.

20 Aug 2026

Glioma microenvironment emerges as key target for future therapies

The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and temozolomide chemotherapy, with median survival rarely exceeding 15 to 18 months.

20 Aug 2026

Only three of 1,357 FDA-cleared AI devices tested patient outcomes

Researchers found that among 1,357 FDA-cleared or approved AI/ML-enabled medical devices, only 34 were linked to registered clinical trials and just three had been evaluated for patient-centered outcomes. The study highlights major gaps in prospective testing, demographic representation, transparency, and evidence showing whether medical AI meaningfully improves patients’ health.

20 Aug 2026

What happens to your diet when you get better at cooking?

Cooking-skills interventions were associated with healthier dietary behaviors in healthy adults, including greater fruit and vegetable intake, improved diet quality, and greater cooking confidence. However, the certainty of evidence was low to very low, and too little evidence was available to determine whether cooking skills affect nutritional status.

20 Aug 2026

Federal and industry sponsors play complementary roles in cancer clinical trials

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.

20 Aug 2026

Study shows how prostate tumors rewire metabolism to resist therapy

Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to a study by Weill Cornell Medicine investigators.

20 Aug 2026

New AI framework improves reliability of cancer pathology diagnosis

Cancer diagnoses directly affect treatment decisions and prognosis and can even have life-altering consequences.

20 Aug 2026

Active screening cuts colorectal cancer death risk drastically

People who take part in screening for colorectal cancer may have as much as 43 per cent lower risk of dying from the disease, according to new estimates published in JAMA Network Open by researchers at Karolinska Institutet and Umeå University in Sweden.

20 Aug 2026

Review examines how medical imaging foundation models are moved toward clinical use

AI is already widely used for lesion detection, disease classification, and outcome prediction in medical imaging, but most systems remain narrowly designed for one task and depend heavily on expert-labelled data.

20 Aug 2026

Vibration isolation in drug discovery research

Vibration isolation supports high-resolution microscopy in drug discovery, enabling stable imaging environments and reliable data at the nanometer scale.

From TMC Vibration Control 20 Aug 2026

New studies reveal hidden control hub for MYC-driven cancers

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, PhD, associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys Medical Discovery Institute, establish a unified framework that governs one of cancer's most powerful master regulators.

19 Aug 2026

A single blood test could offer a glimpse of disease risk years in advance

Machine learning-derived cellular aging clocks mapped more than 7,000 plasma proteins to over 40 cell types, revealing marked differences in how individual cell populations age. These blood-based signatures were associated with future risks of Alzheimer’s disease, ALS, lung cancer, type 2 diabetes, and mortality across follow-up extending to 15 years.

19 Aug 2026